微载体市场- 按产品（消耗品{介质、微载体珠}、设备{生物反应器、细胞计数器}）、应用（生物製药生产、再生医学）、最终用户（CRO、研究机构）、全球预测， 2024 - 2032 年

Microcarriers Market - By Products (Consumables {Media, Microcarrier Beads}, Equipment {Bioreactor, Cell Counter}), Application (Biopharmaceutical Production, Regenerative Medicine), End-user (CROs, Research Institutes), Global Forecast, 2024 - 2032

出版日期: 2024年02月07日 | 出版商:

Global Market Insights Inc. | 英文 230 Pages | 商品交期: 2-3个工作天内

价格

简介目录

受细胞培养过程中越来越多地采用微载体、研发活动的进步、传统细胞培养过程之外的应用扩展以及对基于细胞的疗法和生物製剂的需求不断增长的推动，全球微载体市场规模将于2024-2032 年以9.5% 的复合年增长率成长。

城市化导致对医疗保健服务的需求增加，包括利用细胞技术的先进医疗和疗法。据世界银行称，目前，全球至少有一半人口居住在城市地区。资料显示，2045年，全球城市人口将激增1.5倍，达到60亿。随着越来越多的人迁移到城市地区，对生物製药产品、再生医学和个人化治疗的需求越来越大，以满足人口稠密的城市社区的医疗保健需求。这一趋势推动了对微载体的需求，微载体对于生产用于治疗城市环境中流行的各种疾病的细胞疗法、疫苗和生物製剂至关重要。

微载体市场根据设备、产品、应用、最终用户和地区进行分类。

到 2032 年，设备领域将大幅成长，因为基于微载体的细胞培养系统的先进设备和技术的可用性提高了製程效率、可扩展性和可重复性。生物反应器、旋转瓶和细胞培养容器等设备可支持微载体上的细胞培养，有助于生产大量用于各种应用的细胞。随着生物製药和生物技术公司投资最先进的设备来优化细胞培养过程，预计该细分市场将进一步成长。

到 2032 年，再生医学领域将占据相当大的微载体市场份额，因为微载体用于再生医学应用，包括组织工程、细胞治疗和器官再生。这些生物相容性支架提供了有利于细胞附着、增殖和分化的三维微环境，从而能够开发先进的再生疗法。随着对个人化医疗和慢性病治疗的日益关注，再生医学应用中对微载体的需求预计将进一步飙升，推动市场扩张。

在生物製药研发投资增加、生物技术产业不断扩大以及细胞疗法需求不断增长的推动下，亚太地区微载体产业将在 2032 年实现令人称道的成长。中国、印度、韩国和日本等国家处于生物製药创新和再生医学研究的前沿，为成长做出了贡献。此外，支持性的政府措施、有利的监管环境以及学术界和工业界之间的合作进一步推动了该地区的市场成长。

产业生态系统分析
产业影响力
- 成长动力
  - 癌症和慢性病病例不断增加
  - 细胞培养技术的进步
  - 生物技术和生命科学领域的投资不断增加
- 产业陷阱与挑战
  - 生物相容性和免疫原性问题
  - 无血清培养基成本高
成长潜力分析
监管环境
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪錶板

第 5 章：市场估计与预测：按产品分类，2018 年 - 2032 年

主要趋势
耗材
- 微载体珠
  - 胶原蛋白涂层珠
  - 阳离子珠
  - 蛋白质包被的珠子
  - 未经处理的珠子
  - 其他微载体珠
- 媒体
  - 血清培养基
  - 无血清培养基
  - 其他媒体
- 试剂
- 其他消耗品
装置
- 生物反应器
  - 免洗生物反应器
  - 不銹钢生物反应器
- 培养容器
- 细胞计数器
- 过滤系统
- 其他设备

第 6 章：市场估计与预测：按应用分类，2018 年 - 2032 年

主要趋势
生物製药生产
- 疫苗生产
- 治疗药物生产
再生医学
其他应用

第 7 章：市场估计与预测：按最终用户划分，2018 年 - 2032 年

主要趋势
製药和生物技术公司
CRO 和 CMO
学术及研究机构
细胞库

第 8 章：市场估计与预测：按地区划分，2018 年 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 中东和非洲其他地区

第 9 章：公司简介

Bio-Rad Laboratories, Inc.
Corning Incorporated
Cytiva
denovoMATRIX GmbH
Eppendorf AG
Fujiform Holdings Corporation
Lonza Group AG
Merck KGaA
Sartorious AG
Thermo Fisher Scientific Inc.

简介目录

Product Code: 8058

Global Microcarrier Market Size will grow at 9.5% CAGR during 2024-2032, driven by Increasing adoption of microcarriers in cell culture processes, advancements in R&D activities, expanding applications beyond traditional cell culture processes, and rising demand for cell-based therapies and biologics.

Urbanization leads to an increase in demand for healthcare services, including advanced medical treatments and therapies that utilize cell-based technologies. According to the World Bank, currently, at least half of the global population resides in urban areas. As per data, by 2045, the world's urban population will surge by 1.5 times to reach 6 billion. As more people move to urban areas, there is a greater need for biopharmaceutical products, regenerative medicine, and personalized therapies to address the healthcare needs of densely populated urban communities. This trend drives the demand for microcarriers, which are essential in the production of cell-based therapies, vaccines, and biologics used to treat various diseases prevalent in urban settings.

The Microcarrier Market is classified based on equipment, product, application, end-user, and region.

The equipment segment will grow substantially by 2032, as the availability of advanced equipment and technologies for microcarrier-based cell culture systems enhances process efficiency, scalability, and reproducibility. Equipment such as bioreactors, spinner flasks, and cell culture vessels support the cultivation of cells on microcarriers, facilitating the production of large quantities of cells for various applications. As biopharmaceutical and biotechnology companies invest in state-of-the-art equipment to optimize cell culture processes, further segment growth is anticipated.

The regenerative medicine segment will capture a decent Microcarrier Market share by 2032, as microcarriers are used in regenerative medicine applications, including tissue engineering, cell therapy, and organ regeneration. These biocompatible scaffolds provide a three-dimensional microenvironment conducive to cell attachment, proliferation, and differentiation, enabling the development of advanced regenerative therapies. With the growing focus on personalized medicine and the treatment of chronic diseases, the demand for microcarriers in regenerative medicine applications is expected to further soar, driving market expansion.

Asia Pacific Microcarriers Industry will register commendable growth through 2032, driven by increasing investment in biopharmaceutical research and development, expanding biotechnology industry, and rising demand for cell-based therapies. Countries like China, India, South Korea, and Japan are at the forefront of biopharmaceutical innovation and regenerative medicine research, contributing to the growth. Additionally, supportive government initiatives, a favorable regulatory environment, and collaborations between academia and industry further propel market growth in the region.

Chapter 1 Methodology & Scope

1.1 Market definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculation
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing cases of cancer and chronic diseases
  - 3.2.1.2 Advancements in cell culture technologies
  - 3.2.1.3 Rising investments in biotechnology and life sciences
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Biocompatibility and immunogenicity concerns
  - 3.2.2.2 High cost associated with serum-free media
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Consumables
- 5.2.1 Microcarrier beads
  - 5.2.1.1 Collagen coated beads
  - 5.2.1.2 Cationic beads
  - 5.2.1.3 Protein coated beads
  - 5.2.1.4 Untreated beads
  - 5.2.1.5 Other microcarrier beads
- 5.2.2 Media
  - 5.2.2.1 Serum based media
  - 5.2.2.2 Serum-free media
  - 5.2.2.3 Other media
- 5.2.3 Reagents
- 5.2.4 Other consumables
5.3 Equipment
- 5.3.1 Bioreactor
  - 5.3.1.1 Single-use bioreactor
  - 5.3.1.2 Stainless steel bioreactor
- 5.3.2 Culture vessel
- 5.3.3 Cell counter
- 5.3.4 Filtration system
- 5.3.5 Other equipment

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Biopharmaceutical production
- 6.2.1 Vaccine production
- 6.2.2 Therapeutics production
6.3 Regenerative medicine
6.4 Other applications

Chapter 7 Market Estimates and Forecast, By End-User, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Pharmaceutical & biotechnology companies
7.3 CROs & CMOs
7.4 Academic & research institutes
7.5 Cell banks

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East and Africa